Literature DB >> 8311535

Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients.

E T Koh1, A Seow, B Ong, P Ratnagopal, H Tjia, H H Chng.   

Abstract

OBJECTIVES: To determine possible similarities and differences in clinical and laboratory features and treatment response between patients in Singapore with polymyositis (PM) and dermatomyositis (DM) and reported series.
METHODS: Case records of adult patients (16 years old and above) referred to the 3 main electromyographic (EMG) laboratories in Singapore between 1 June 1986 and 31 May 1991 were reviewed if the referring diagnosis was myositis or myopathy for investigation. A computer search for adult patients with a diagnosis of PM/DM (ICD codes 710.3, 710.4, 517.8) who attended the main rheumatology and neurology centre during this period was also carried out. The criteria for PM/DM proposed by Bohan and Peter was adopted.
RESULTS: The incidence of PM/DM was 7.7 cases per million population per year. There were 35 PM and 40 DM cases with a median age at diagnosis of 50.7 years (SD: 16.7) and significantly more females in the PM group (p < 0.05). At presentation, 86.7% had proximal myopathy, 34.7% had arthralgia/arthritis and 18.7% had cutaneous vasculitis. The creatine kinase level was elevated in 89.3% of patients and positive EMG and muscle biopsy in 79.4% and 76.4% respectively. Systemic lupus erythematosus was the commonest associated connective tissue disease. The percentage of patients with malignancy was higher in DM compared with PM (p < 0.01) and they were significantly older (mean age 61.8 years) (p < 0.001). Patients who achieved remission were significantly younger (mean age 46.4 years, p < 0.05). The overall mortality rate was 26.7% with infection and malignancy as the main causes of death.
CONCLUSION: The results of the study suggest ethnicity does not influence the expression of PM/DM in view of the considerable similarities in frequency and clinical expression of disease in the population studied compared with series from other countries.

Entities:  

Mesh:

Year:  1993        PMID: 8311535      PMCID: PMC1005215          DOI: 10.1136/ard.52.12.857

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  PATTERNS OF POLYMYOSITIS AND THEIR RESPONSES TO TREATMENT.

Authors:  C M PEARSON
Journal:  Ann Intern Med       Date:  1963-12       Impact factor: 25.391

3.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

4.  The epidemiology of polymyositis.

Authors:  T A Medsger; W N Dawson; A T Masi
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

5.  Factors affecting survivorship in polymyositis. A life-table study of 124 patients.

Authors:  T A Medsger; H Robinson; A T Masi
Journal:  Arthritis Rheum       Date:  1971 Mar-Apr

6.  Dermatomyositis: a clinical investigation of twenty-three cases in Hong Kong.

Authors:  K O Wong
Journal:  Br J Dermatol       Date:  1969-07       Impact factor: 9.302

7.  Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis.

Authors:  A L Rose; J N Walton
Journal:  Brain       Date:  1966-12       Impact factor: 13.501

8.  Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment.

Authors:  G Ramírez; R A Asherson; M A Khamashta; R Cervera; D D'Cruz; G R Hughes
Journal:  Semin Arthritis Rheum       Date:  1990-10       Impact factor: 5.532

9.  Polymyositis: its presentation, morbidity and mortality.

Authors:  R DeVere; W G Bradley
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

10.  Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases.

Authors:  N Basset-Seguin; J C Roujeau; R Gherardi; J C Guillaume; J Revuz; R Touraine
Journal:  Arch Dermatol       Date:  1990-05
View more
  25 in total

1.  Autoantibody profiles in the sera of European patients with myositis.

Authors:  R Brouwer; G J Hengstman; W Vree Egberts; H Ehrfeld; B Bozic; A Ghirardello; G Grøndal; M Hietarinta; D Isenberg; J R Kalden; I Lundberg; H Moutsopoulos; P Roux-Lombard; J Vencovsky; A Wikman; H P Seelig; B G van Engelen ; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

Review 2.  Prognosis of polymyositis and dermatomyositis.

Authors:  A C F Hui; S M Wong; T Leung
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

3.  Long-term follow-up of 62 patients with myositis.

Authors:  Janneke van de Vlekkert; Jessica E Hoogendijk; Marianne de Visser
Journal:  J Neurol       Date:  2014-05       Impact factor: 4.849

4.  Moderate incidence of prior rheumatoid arthritis in patients with polymyositis and dermatomyositis.

Authors:  Takao Nagashima; Masahiro Iwamoto; Seiji Minota
Journal:  Clin Rheumatol       Date:  2011-04-27       Impact factor: 2.980

5.  Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.

Authors:  Luciena Cegatto Martins Ortigosa; Vitor Manuel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 6.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 7.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 8.  Morbidity and mortality in adult polymyositis and dermatomyositis.

Authors:  Isabelle Marie
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

9.  Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.

Authors:  K P Ng; F Ramos; S M Sultan; D A Isenberg
Journal:  Clin Rheumatol       Date:  2009-04-23       Impact factor: 2.980

10.  Clinical characteristics and outcomes of juvenile and adult dermatomyositis.

Authors:  Sang-Jun Na; Seung Min Kim; Il Nam Sunwoo; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.